<DOC>
	<DOCNO>NCT02868489</DOCNO>
	<brief_summary>The hypothesis determine effect bacillus coagulans galactomannans ( LactoWise® ) administration microbiota obese patient undergo sleeve gastrectomy observe standard protocol measurement patient follow sleeve gastrectomy : blood marker weight , addition incorporate Gastrointestinal Quality Life Index ( GIQLI )</brief_summary>
	<brief_title>Effect Bacillus Coagulans Galactomannans Obese Patients Undergoing Sleeve Gastrectomy</brief_title>
	<detailed_description>Loma Linda University 's School Allied Health Professions collaboration Metabolic Bariatric Surgery Department Surgery Division conduct research evaluate influence LactoWise® ( proprietary blend probiotic prebiotic - bacillus coagulans/galactomannans , respectively ) normal microbiota obese patient post bariatric sleeve gastrectomy . Pre-surgery , participant require sign consent form complete Gastro-Intestinal Quality Life Index ( GIQLI ) . A total 60 bariatric sleeve patient recruit investigation . Post-surgery participant randomize two group , one receive LactoWise® one control ( placebo ) . The LactoWise® blend 300 mg bacillus coagulans galactomannans contains around 4.5 billion live cell . Daily intake capsule couple bariatric sleeve standard care conduct duration 3 month , anticipate clinical timeline . Participants also ask complete quality life questionnaire follow follow-ups post-surgery : 2nd week , 6th week , 3rd month . Outcome measure standard protocol bariatric sleeve patient Metabolic Bariatric Surgery Department include weight measurement , blood work . In addition standard care procedures research procedure add GIQLI . Pre post clinical consults , administration probiotic/prebiotic formula , follow-ups conduct Faculty Medical Offices - General Surgery - Bariatric Clinic Loma Linda University Health .</detailed_description>
	<criteria>Patient bariatric sleeve surgery Ages 1870 Consent complete GIQOL questionnaire Commit consistent use LactoWise® placebo assign study period None sleeve bariatric surgery patient Have compromise immunity poorly control system Presence concurrent active infection Physically disable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Microbiota</keyword>
</DOC>